Dr. Michael Kapiloff

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Michael Kapiloff. Improve your application with a focused, well-structured draft.

Biography

Dr. Michael S. Kapiloff is a Reinhard Family Professor of Ophthalmology at Stanford University. He earned his PhD in Biomedical Sciences from the University of California, San Diego in 1991 and an MD in 1992, completing his residency in General Pediatrics at the University of Utah in 1995. His research focuses on the basic molecular mechanisms of disease in retinal ganglion cells and cardiac myocytes. Previously, he held various academic positions including Research Assistant Professor and Assistant Professor at Oregon Health Science University, and as a tenured Professor at the University of Miami. His lab is dedicated to the role of intracellular signal transduction and has worked on new AAV gene therapies aimed at preventing and treating heart failure and eye diseases. He has received numerous awards throughout his career, including the Beneficial-Hodson Scholar and was named a Fellow of the American Heart Association. Kapiloff is also associated with the Stanford Cardiovascular Institute, focusing on the translational aspects of his research.

Research Interests

Experience

Professor (Research)

2017-07-01 — Present

Stanford University • Palo Alto, California

Professor of Ophthalmology with research focus on cardiac signal transduction and its implications for retinal diseases.

Director of Cardiac Signal Transduction Laboratory

2007-01-01 — 2017-07-01

University of Miami Miller School of Medicine • Miami, Florida

Led the laboratory focused on cardiac disease research.

Assistant Professor of Pediatrics

1999-01-01 — 2007-01-01

Oregon Health Science University • Portland, Oregon

Conducted research on pediatric subjects within the academic medical center.

Patents

Treatment Heart Disease Disruption Anchoring PP2A

US 11,938,198 2024-03-26

Patent involving a treatment process for heart disease.

Compositions Treating Heart Disease Inhibiting Action mAKAPβ

US 11,931,402 2024-03-19

Novel compositions for heart disease treatment.

Compositions treating heart disease inhibiting action mAKAPβ

US 11,229,679 2022-01-25

Innovations in treatment compositions for heart disease.

Treatment Heart Disease Inhibition Action Muscle A-Kinase Anchoring Protein (mAKAP)

US 10,907,153 2021-02-02

A treatment method patent focused on heart disease.

Compositions Treating Heart Disease Inhibiting Action mAKAPβ

US 10,617,737 2020-04-14

Compositions targeted at inhibiting actions related to mAKAPβ.

Treatment Myocardial Infarction Inhibiting Action mAKAPβ

US 9,937,228 2018-04-10

Patent for treatment methods involving myocardial infarction.

TREATMENT HEART DISEASE INHIBITION ACTION RIBOSOMAL S6 KINASE 3 (RSK3)

US 9,132,174 2015-09-15

Patent covering treatment methods relating to heart disease.

Requirements for Stanford University

Doctorate Program
Requirements
GPA Requirement
Required:3.5
TOEFL
Listening
Required:26
Reading
Required:26
Writing
Required:26
Speaking
Required:26
Total
Required:100
GRE General
Verbal
Required:160
Quantitative
Required:165
Analytical Writing
Required:4.5
Overall
Required:4.5
Prerequisites
Bachelor degree from an accredited institution Strong background in mathematics and programming
Application Checklist
  • Statement of Purpose
  • Three letters of recommendation
  • Official transcripts
  • Resume/CV
Specialization Notes

The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.